Julphar Saudi Arabia granted cGMP certification
Source: AETOS Wire for Julphar , Author: Posted by BI-ME staff
Posted: Tue February 13, 2018 11:43 am

UAE. -- (AETOSWire) -- Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has been awarded Current Good Manufacturing Practice (cGMP) approval by the Saudi Food and Drug Authority (SFDA).

Julphar Saudi Arabia, a joint venture between Julphar and its local partner Cigalah Group, is the first pharmaceutical company in King Abdullah Economic City (KAEC) to earn full cGMP certification on its first inspection. 

Commenting on the announcement, Sheikh Abdullah Bin Faisal Al Qasimi, Chairman of Julphar Saudi Arabia, said: “Congratulations to everyone who made this important certification possible. Saudi Arabia is our largest market and we continue to see a strong opportunity for growth in the country.

“This certificate will undoubtedly add value to our organization, strengthen our commitment to the health sector of Saudi Arabia and contribute to Julphar’s 2020 vision of expanding our manufacturing presence in the region.”

The SAR 300 million state-of-the-art manufacturing facility was officially inaugurated in April 2017 by Dr Tawfiq Al Rabiah the Minister of Health Kingdom of Saudi Arabia. The manufacturing plant has the capacity to produce 1 billion tablets, 300 million capsules and 30 million bottles of syrups and suspensions per year.

Ibrahim Al Makhadi, General Manager of Julphar Saudi Arabia, said: "We are delighted to receive cGMP approval, an achievement that paves the way for a strong business presence in the country in accordance with the 2030 vision of the Kingdom of Saudi Arabia.

“I would like to take this opportunity to congratulate and thank all my Julphar Saudi team, who have diligently, eagerly, and assiduously burned midnight oil to earn this accomplishment. I would also like to thank all the members of Julphar Ras Al Khaimah who supported us in achieving this objective.”

Photo Captions:
1. (above)  Julphar logo
2. (inset)   For illustrative purposes only (File photo)

About Julphar
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, was established in 1980 under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi. The company employs 5,000 people and distributes a wide range of products to more than 50 countries on five continents across the globe.

Julphar’s business is centered on three core units – Diabetes Solutions, General Medicines, and its consumer division, Julphar Life. The company’s product portfolio of tablets, liquids, creams and injectables target major therapeutic segments including Family Care, Gastrology, Pain and Wound Management, Antibiotic, Cardiovascular and Metabolism.

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: May 22, 2018
UAE. Cyber-criminals are turning their attention to the supply chain as a new means to exploit business data.
date:Posted: May 21, 2018
UAE. A new defence is being developed that will allow companies to tackle the latest threats as soon as they appear on the network; Machine learning enables AI to detect patterns in all sorts of data sources and create behaviours based on recognized patterns.
date:Posted: May 17, 2018
UAE. The report states that 50% of SME funding applications are rejected by banks and that alternative trade finance, powered by FinTech and Blockchain, is on the rise.
dhgate